Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 11 October 2022
Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting
Press Release, 3 October 2022
Kuros Biosciences Appoints Chris Fair as Chief Operating Officer
Press Release, 15 September 2022
Kuros Biosciences announces successful CHF 6.0 million private placement
Press Release, 23 August 2022
Kuros Biosciences’ MagnetOs Bone Graft Successfully Achieves Three Key Milestones
Kuros Interim Results, 2022
English version
Press Release, 9 August 2022
Kuros Biosciences reports results for the first six months of 2022